These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38679040)

  • 21. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
    Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
    Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 Is Associated With Lower Group B Streptococcus Capsular and Surface-Protein IgG Antibody Levels and Reduced Transplacental Antibody Transfer in Pregnant Women.
    Dangor Z; Kwatra G; Izu A; Adrian P; van Niekerk N; Cutland CL; Adam Y; Velaphi S; Lala SG; Madhi SA
    J Infect Dis; 2015 Aug; 212(3):453-62. PubMed ID: 25651843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
    Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
    Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.
    Baker CJ; Rench MA; Fernandez M; Paoletti LC; Kasper DL; Edwards MS
    J Infect Dis; 2003 Jul; 188(1):66-73. PubMed ID: 12825173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections.
    Dangor Z; Lala SG; Kwatra G; Madhi SA
    Curr Opin Infect Dis; 2016 Jun; 29(3):262-7. PubMed ID: 26926474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo.
    Arjunaraja S; Paoletti LC; Snapper CM
    J Immunol; 2012 Jun; 188(11):5238-46. PubMed ID: 22523389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
    Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
    Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
    Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S
    Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.
    Bianchi-Jassir F; Paul P; To KN; Carreras-Abad C; Seale AC; Jauneikaite E; Madhi SA; Russell NJ; Hall J; Madrid L; Bassat Q; Kwatra G; Le Doare K; Lawn JE
    Vaccine; 2020 Oct; 38(43):6682-6694. PubMed ID: 32888741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Multiplex Immunoassays for Quantification of IgG against Group B
    Buffi G; Galletti B; Stella M; Proietti D; Balducci E; Romano MR; Mori E; Fabbrini M; Giuliani MM; Berti F; Margarit I
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery.
    Campbell JR; Hillier SL; Krohn MA; Ferrieri P; Zaleznik DF; Baker CJ
    Obstet Gynecol; 2000 Oct; 96(4):498-503. PubMed ID: 11004347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
    Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
    J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
    Nurkka A; Ahman H; Korkeila M; Jäntti V; Käyhty H; Eskola J
    Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study.
    Matur RV; Thuluva S; Gunneri S; Yerroju V; Reddy Mogulla R; Thammireddy K; Paliwal P; Mahantshetty NS; Ravi MD; Prashanth S; Verma S; Narayan JP
    Vaccine; 2024 May; 42(13):3157-3165. PubMed ID: 38637211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A maternal vaccine against group B Streptococcus: past, present, and future.
    Chen VL; Avci FY; Kasper DL
    Vaccine; 2013 Aug; 31 Suppl 4(0 4):D13-9. PubMed ID: 23973342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studies.
    Izu A; Kwatra G; Madhi SA; Rigat F
    BMC Med Res Methodol; 2022 Mar; 22(1):85. PubMed ID: 35350991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody responses in invasive group B streptococcal infection in adults.
    Wessels MR; Kasper DL; Johnson KD; Harrison LH
    J Infect Dis; 1998 Aug; 178(2):569-72. PubMed ID: 9697746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
    Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
    Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
    Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
    J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.